Admission Date:  [**2139-4-25**]              Discharge Date:   [**2139-4-26**]  Date of Birth:  [**2065-6-3**]             Sex:   M  Service: MEDICINE  Allergies: Phenergan  Attending:[**Last Name (NamePattern4) 290**] Chief Complaint: transfer for ERCP  Major Surgical or Invasive Procedure: ERCP with sphincterotomy and common bile duct temporary stent placement.
History of Present Illness: 73 yo man with COPD on 3L home O2, CAD s/p CABG ~12 yrs ago, atrial fibrillation on coumadin, HTN, HL, OSA on CPAP who presented to [**Hospital1 392**] on [**4-24**] with abdominal pain that started earlier that day.
The pain was not associated with food and not releived by OTC antiacids.
He remained hemodynamically stable, he received one dose of gentamycin and was subsequently started on Zosyn/Flagyl, given 2 units of FFP and transfered to [**Hospital1 18**] for ERCP.
Patient received ampicillin/gentamycin prior to procedure and was intubated.
ERCP revealed two 1 cm stones, multiple smaller stones, CBD dilation to 12 mm, a stent was placed and a sphynteromy done.
Past Medical History: CAD s/p CABG AFib on coumadin COPD on home O2 at 3L OSA on CPAP DM II HTN HL Melanoma s/p resection Asthma GERD ?
Denies EtOH  Family History: Non-contributory  Physical Exam: General: Alert, oriented, no acute distress HEENT: Sclera anicteric, DMM, oropharynx clear Neck: supple Lungs: Pursed lip breathing, clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema   Pertinent Results: Labs:  [**2139-4-25**] 05:58PM   WBC-12.1* RBC-4.43* HGB-11.8* HCT-36.9* MCV-83 MCH-26.7* MCHC-32.0 RDW-20.7* [**2139-4-25**] 05:58PM   PT-22.7* PTT-30.0 INR(PT)-2.1* [**2139-4-25**] 05:58PM   GLUCOSE-223* UREA N-41* CREAT-2.0* SODIUM-138 POTASSIUM-5.1 CHLORIDE-103 TOTAL CO2-19* ANION GAP-21* ALT(SGPT)-340* AST(SGOT)-238* ALK PHOS-253* AMYLASE-564* TOT BILI-5.5* CALCIUM-8.6 PHOSPHATE-5.3* MAGNESIUM-2.0 [**2139-4-26**] 05:43AM BLOOD WBC-8.3 RBC-4.04* Hgb-10.7* Hct-33.9* MCV-84 MCH-26.5* MCHC-31.6 RDW-21.1* Plt Ct-144* [**2139-4-26**] 05:43AM BLOOD PT-19.2* INR(PT)-1.8* [**2139-4-26**] 05:43AM BLOOD Glucose-200* UreaN-45* Creat-1.9* Na-141 K-4.3 Cl-106 HCO3-21* AnGap-18 ALT-281* AST-187* AlkPhos-240* Amylase-312* TotBili-3.9*  ERCP Report: Date: Saturday, [**2139-4-25**] Endoscopist(s): [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 52995**], M.D.
: [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **], MD     Anesthesiologists: [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 25731**], MD     Assisting Nurse(s)/ Other Personnel: [**Name6 (MD) 39403**] [**Name8 (MD) **], RN Birth Date: [**2065-6-3**] (73 years) Instrument: TJF-160VF ([**Numeric Identifier 52997**])   [**Numeric Identifier 52998**] Indications: A level 4 consult was performed Fever, RUQ abdominal pain, jaundice, and an abnormal MRCP with dilated bile ducts and choledocholithiasis all consistent with cholangitis  Medications: General Anesthesia Ampicillin 2 gm IV Gentamycin 60 mg IV  Procedure: The procedure, indications, preparation and potential complications were explained to the patient, who indicated his understanding and signed the corresponding consent forms.
The procedure was not difficult.
The patient tolerated the procedure well.
Cannulation:  On the first attempt, cannulation of the biliary duct was successful and deep with a sphincterotome after a guidewire was placed.
The procedure was not difficult.
A sphincterotomy was performed in the 12 o'clock position using a sphincterotome over an existing guidewire.
A 9cm by 10FR plastic biliary stent was placed successfully in the CBD using a Microvasive 10FR stent introducer kit.
On the first attempt, cannulation of the biliary duct was successful and deep with a sphincterotome after a guidewire was placed.
The procedure was not difficult.
A sphincterotomy was performed in the 12 o'clock position using a sphincterotome over an existing guidewire.
A 9cm by 10FR plastic biliary stent was placed successfully in the CBD using a Microvasive 10FR stent introducer kit.
NPO overnight with aggressive IV hydration.
He will need several liters of NS upfront and then a high infusion rate of 250-300cc/hr for cholangitis and gallstone pancreatitis.
Continue IV antibiotics for cholangitis.
Transfuse 2 units of FFP and please give 2.5 mg of vitamin K. No coumadin, ASA, plavix, or NSAIDs for 5-7 days.
Repeat ERCP with Dr. [**Last Name (STitle) **] ([**Telephone/Fax (1) 10532**] in 4 weeks for stent removal.
He will need to hold coumadin for 5 days prior to this procedure.
Additional notes: The procedure was performed by the ERCP fellow and Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 52995**].
Patient underwent procedure w/o complications, found to have two 1 cm stones, multiple small ones, a dilated CBD.
Sphincterotomy was performed and a temporary stent was placed.
His LFT's improved after procedure and Zosyn IV was continued.
He received IVF hydration and his renal function improved slightly.
His lisinopril, lasix and digoxin were held due to ARF.
Patient received gentamycin at the OSH and at prior to ERCP which could cause renal toxicity.
Atenolol and verapamil were continued.
Atenolol and verapamil were continued.
He received 2 units of FFP and 5 mg of vitamin K for reversal of INR post-procedure as there was a risk for bleeding.
Coumadin was held.
Home meds were continued.
He was on CPAP overnight for OSA.
GERD: He received IV pantoprazole while NPO and transitioned to PO pantoprazole one a diet was resumed.
DM II: Metformin and lantus were held due to ARF and NPO status respectively.
Patient continued on humalog SS.
Meds continued or held as above.
HL: Simvastatin was held due to liver injury.
CODE STATUS: Full Code  Medications on Admission: HOME MEDS:  Malatonin 5/lorazepam 0.5mg QHS Advair 500/50 [**Hospital1 **] Spiriva 1 inhalation daily Proair IH prn Atenolol 50 mg daily Digoxin 0.25 mg daily Lisinopril 10 mg daily Metformin 1000 mg [**Hospital1 **] Verapamil 240 mg qam, 120 mg qpm Paroxetine 20 mg daily Omeprazole 20 mg daily Furosemide 80 mg daily Simvastatin 80 mg daily Coumadin 5 mg daily Aricept 10 mg daily Lantus Unknown dose Humalog SS ....
Atenolol 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Fluticasone-Salmeterol 500-50 mcg/Dose Disk with Device Sig: One (1) Disk with Device Inhalation [**Hospital1 **] (2 times a day).
Paroxetine HCl 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Donepezil 5 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime).
Cyanocobalamin 500 mcg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Ferrous Sulfate 300  mg (60 mg Iron) Tablet Sig: One (1) Tablet PO BID (2 times a day).
Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1)  Inhalation Q4H (every 4 hours) as needed for SOB.
Acetaminophen 500 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for pain.
Verapamil 120 mg Tablet Sig: Two (2) Tablet PO QAM (once a day (in the morning)).
Verapamil 120 mg Tablet Sig: One (1) Tablet PO QPM (once a day (in the evening)).
Piperacillin-Tazobactam 2.25 gram Recon Soln Sig: One (1) Recon Soln Intravenous Q6H (every 6 hours) for 7 days.
Spiriva with HandiHaler 18 mcg Capsule, w/Inhalation Device Sig: One (1)  Inhalation once a day.
Omeprazole 20 mg Capsule, Delayed Release(E.C.)
Lantus 100 unit/mL Cartridge Sig: unknown  Subcutaneous once a day.
Humalog 100 unit/mL Cartridge Sig: 2-10 units Subcutaneous four times a day: per sliding scale.
Discharge Disposition: Extended Care  Discharge Diagnosis: Primary Diagnosis: Choledocholithiasis Ascending cholangitis  Secondary diagnosis: Coronary artery disease Atrial fibrillation COPD OSA Hypertension Hyperlipidemia Dementia   Discharge Condition: Mental Status: Clear and coherent Level of Consciousness: Alert and interactive Activity Status: Ambulatory - requires assistance or aid (walker or cane)   Discharge Instructions: You were transfered from [**First Name5 (NamePattern1) 392**] [**Last Name (NamePattern1) **] to [**Hospital1 18**] for ERCP.
You underwent this procedure and a temporary stent was placed in your bile duct.
DO NOT take coumadin (warfarin), aspirin, plavix (clopidogrel), or non steroidal anti inflammatory drugs (such as ibuprofen or naproxen) for the next 5-7 days.
You will need to hold your coumadin 5 days before this procedure.
You were noted to be in renal failure, so your lasix, digoxin, and lisinopril were held.
Due to your elevated liver function tests, simvastatin and metformin were stopped.
Please schedule a repeat ERCP with Dr. [**Last Name (STitle) **] ([**Telephone/Fax (1) 10532**] in 4 weeks for stent removal.
You will need to stop taking coumadin for 5 days prior to this procedure.
